Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Genetworx is a U.S.-based molecular diagnostics company specializing in advanced testing solutions, including pharmacogenomics (PGx), infectious disease testing (including COVID-19), and personalized medicine. Acquired by Eurofins Scientific in 2021, Genetworx leverages cutting-edge technology and scientific expertise to deliver accurate and timely results, empowering healthcare providers and patients to make informed decisions. Their services cater to a wide range of clients, including physician offices, hospitals, long-term care facilities, and enterprise-level organizations, focusing on improving patient outcomes through precision diagnostics.
Serves as the central hub for Genetworx's advanced molecular diagnostic testing, research and development activities, high-complexity laboratory operations, and corporate administration.
State-of-the-art, CLIA-certified and CAP-accredited laboratory facilities equipped for high-throughput molecular testing, including PCR, next-generation sequencing (NGS), and advanced RNA/DNA extraction technologies.
A dynamic, collaborative, and innovative environment focused on scientific excellence, precision, and rapid turnaround times to support patient care and public health initiatives. Emphasis on quality assurance, regulatory compliance, and continuous improvement in diagnostic services.
The Glen Allen facility is critical to Genetworx's operations, enabling the company to provide a wide range of diagnostic services across the U.S. Its location offers access to a skilled workforce and logistical advantages for sample processing.
Genetworx primarily serves the United States market with its advanced diagnostic testing services from its Virginia headquarters. As part of Eurofins Scientific, a global group of laboratories, Genetworx benefits from an extensive international network. This allows for broader reach in terms of research collaborations, access to global scientific expertise, and potentially supporting international clinical trials or specialized diagnostic requests through the Eurofins network. Core functions supported include specialized molecular testing, pharmacogenomics, and infectious disease diagnostics.
4951 Lake Brook Drive, Suite 100
Glen Allen
VA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Genetworx' leadership includes:
Genetworx has been backed by several prominent investors over the years, including:
Following its acquisition by Eurofins Scientific, Genetworx's leadership structure is integrated within the Eurofins Clinical Diagnostics division. Specific major Genetworx-branded executive hires or departures have not been prominently announced in the public domain in the last 12 months. Leadership transitions typically align with broader Eurofins corporate strategy and integration efforts.
Discover the tools Genetworx uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Genetworx, now part of Eurofins, likely utilizes email formats common within the Eurofins network or maintains its established patterns. Common professional email formats include first initial followed by last name, or first name separated from last name by a period.
f[last]@genetworx.com (e.g., jdoe@genetworx.com) or [first].[last]@genetworx.com (e.g., john.doe@genetworx.com). Post-acquisition, Eurofins formats like [FirstName][LastName]@eurofins.com may also be relevant for broader group interactions.
Format
jdoe@genetworx.com
Example
85%
Success rate
Eurofins Scientific Press Release / GlobeNewswire • October 26, 2021
Eurofins Scientific announced the successful acquisition of Genetworx, a prominent U.S. laboratory specializing in COVID-19 testing, pharmacogenomics, and other molecular diagnostics. This acquisition aimed to expand Eurofins' clinical diagnostic services and genomic testing capabilities within the United States....more
PR Newswire • March 1, 2021
Genetworx announced the opening of its national COVID-19 saliva test kit processing lab in Virginia, featuring new RNA extraction technology. This development significantly increased their testing capacity to 30,000 tests per day, supporting nationwide efforts to combat the pandemic....more
PR Newswire (via empowerDX/Eurofins) • January 25, 2023
While this news is for empowerDX, it mentions: 'empowerDX, a subsidiary of Eurofins Viracor and part of the Eurofins U.S. Clinical Diagnostics network that includes Genetworx and Clinical Enterprise.' This highlights Genetworx's integration within the broader Eurofins network offering diverse testing solutions....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Genetworx, are just a search away.